Home / All Categories / Medical Devices & Consumables / Global NK Cell Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Global NK Cell Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Global NK Cell Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Pages: 100      Published Date: Oct 2019       Category: Medical Devices & Consumables
Description

Scope of the Report:
The global NK Cell Therapy market is valued at 222.5 million USD in 2018 and is expected to reach 395.4 million USD by the end of 2024, growing at a CAGR of 15.5% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of NK Cell Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the NK Cell Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the NK Cell Therapy market by product type and applications/end industries.

Market Segment by Companies, this report covers
    Nektar Therapeutics
    Kiadis Pharma
    Chipscreen Biosciences
    Innate Pharma SA
    Dragonfly Therapeutics
    Affimed
    Nkarta Therapeutics
    Glycostem Therapeutics
    Fate Therapeutics
    NantWorks
    Fortress Biotech

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    NK Cell Therapies
    NK Cell Directed Antibodies

NK Cell agents took the largest market share segment, accounting for 82% and growing fastest

Market Segment by Applications, can be divided into
    Cancer
    Gastrointestinal Diseases
    Others

Cancer was the most widely used area at 66%
Table of Contents

1 NK Cell Therapy Market Overview
    1.1 Product Overview and Scope of NK Cell Therapy
    1.2 Classification of NK Cell Therapy by Types
        1.2.1 Global NK Cell Therapy Revenue Comparison by Types (2019-2024)
        1.2.2 Global NK Cell Therapy Revenue Market Share by Types in 2018
        1.2.3 NK Cell Therapies
        1.2.4 NK Cell Directed Antibodies
    1.3 Global NK Cell Therapy Market by Application
        1.3.1 Global NK Cell Therapy Market Size and Market Share Comparison by Applications (2014-2024)
        1.3.2 Cancer
        1.3.3 Gastrointestinal Diseases
        1.3.4 Others
    1.4 Global NK Cell Therapy Market by Regions
        1.4.1 Global NK Cell Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
        1.4.1 North America (USA, Canada and Mexico) NK Cell Therapy Status and Prospect (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy) NK Cell Therapy Status and Prospect (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) NK Cell Therapy Status and Prospect (2014-2024)
        1.4.4 South America (Brazil, Argentina, Colombia) NK Cell Therapy Status and Prospect (2014-2024)
        1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) NK Cell Therapy Status and Prospect (2014-2024)
    1.5 Global Market Size of NK Cell Therapy (2014-2024)
2 Company Profiles
    2.1 Nektar Therapeutics
        2.1.1 Business Overview
        2.1.2 NK Cell Therapy Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Nektar Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
    2.2 Kiadis Pharma
        2.2.1 Business Overview
        2.2.2 NK Cell Therapy Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Kiadis Pharma NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
    2.3 Chipscreen Biosciences
        2.3.1 Business Overview
        2.3.2 NK Cell Therapy Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Chipscreen Biosciences NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
    2.4 Innate Pharma SA
        2.4.1 Business Overview
        2.4.2 NK Cell Therapy Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Innate Pharma SA NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
    2.5 Dragonfly Therapeutics
        2.5.1 Business Overview
        2.5.2 NK Cell Therapy Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Dragonfly Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
    2.6 Affimed
        2.6.1 Business Overview
        2.6.2 NK Cell Therapy Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Affimed NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
    2.7 Nkarta Therapeutics
        2.7.1 Business Overview
        2.7.2 NK Cell Therapy Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Nkarta Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
    2.8 Glycostem Therapeutics
        2.8.1 Business Overview
        2.8.2 NK Cell Therapy Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 Glycostem Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
    2.9 Fate Therapeutics
        2.9.1 Business Overview
        2.9.2 NK Cell Therapy Type and Applications
            2.9.2.1 Product A
            2.9.2.2 Product B
        2.9.3 Fate Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
    2.10 NantWorks
        2.10.1 Business Overview
        2.10.2 NK Cell Therapy Type and Applications
            2.10.2.1 Product A
            2.10.2.2 Product B
        2.10.3 NantWorks NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
    2.11 Fortress Biotech
        2.11.1 Business Overview
        2.11.2 NK Cell Therapy Type and Applications
            2.11.2.1 Product A
            2.11.2.2 Product B
        2.11.3 Fortress Biotech NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global NK Cell Therapy Market Competition, by Players
    3.1 Global NK Cell Therapy Revenue and Share by Players (2014-2019)
    3.2 Market Concentration Rate
        3.2.1 Top 5 NK Cell Therapy Players Market Share
        3.2.2 Top 10 NK Cell Therapy Players Market Share
    3.3 Market Competition Trend
4 Global NK Cell Therapy Market Size by Regions
    4.1 Global NK Cell Therapy Revenue and Market Share by Regions
    4.2 North America NK Cell Therapy Revenue and Growth Rate (2014-2019)
    4.3 Europe NK Cell Therapy Revenue and Growth Rate (2014-2019)
    4.4 Asia-Pacific NK Cell Therapy Revenue and Growth Rate (2014-2019)
    4.5 South America NK Cell Therapy Revenue and Growth Rate (2014-2019)
    4.6 Middle East and Africa NK Cell Therapy Revenue and Growth Rate (2014-2019)
5 North America NK Cell Therapy Revenue by Countries
    5.1 North America NK Cell Therapy Revenue by Countries (2014-2019)
    5.2 USA NK Cell Therapy Revenue and Growth Rate (2014-2019)
    5.3 Canada NK Cell Therapy Revenue and Growth Rate (2014-2019)
    5.4 Mexico NK Cell Therapy Revenue and Growth Rate (2014-2019)
6 Europe NK Cell Therapy Revenue by Countries
    6.1 Europe NK Cell Therapy Revenue by Countries (2014-2019)
    6.2 Germany NK Cell Therapy Revenue and Growth Rate (2014-2019)
    6.3 UK NK Cell Therapy Revenue and Growth Rate (2014-2019)
    6.4 France NK Cell Therapy Revenue and Growth Rate (2014-2019)
    6.5 Russia NK Cell Therapy Revenue and Growth Rate (2014-2019)
    6.6 Italy NK Cell Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific NK Cell Therapy Revenue by Countries
    7.1 Asia-Pacific NK Cell Therapy Revenue by Countries (2014-2019)
    7.2 China NK Cell Therapy Revenue and Growth Rate (2014-2019)
    7.3 Japan NK Cell Therapy Revenue and Growth Rate (2014-2019)
    7.4 Korea NK Cell Therapy Revenue and Growth Rate (2014-2019)
    7.5 India NK Cell Therapy Revenue and Growth Rate (2014-2019)
    7.6 Southeast Asia NK Cell Therapy Revenue and Growth Rate (2014-2019)
8 South America NK Cell Therapy Revenue by Countries
    8.1 South America NK Cell Therapy Revenue by Countries (2014-2019)
    8.2 Brazil NK Cell Therapy Revenue and Growth Rate (2014-2019)
    8.3 Argentina NK Cell Therapy Revenue and Growth Rate (2014-2019)
    8.4 Colombia NK Cell Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue NK Cell Therapy by Countries
    9.1 Middle East and Africa NK Cell Therapy Revenue by Countries (2014-2019)
    9.2 Saudi Arabia NK Cell Therapy Revenue and Growth Rate (2014-2019)
    9.3 UAE NK Cell Therapy Revenue and Growth Rate (2014-2019)
    9.4 Egypt NK Cell Therapy Revenue and Growth Rate (2014-2019)
    9.5 Nigeria NK Cell Therapy Revenue and Growth Rate (2014-2019)
    9.6 South Africa NK Cell Therapy Revenue and Growth Rate (2014-2019)
10 Global NK Cell Therapy Market Segment by Type
    10.1 Global NK Cell Therapy Revenue and Market Share by Type (2014-2019)
    10.2 Global NK Cell Therapy Market Forecast by Type (2019-2024)
    10.3 NK Cell Therapies Revenue Growth Rate (2014-2024)
    10.4 NK Cell Directed Antibodies Revenue Growth Rate (2014-2024)
11 Global NK Cell Therapy Market Segment by Application
    11.1 Global NK Cell Therapy Revenue Market Share by Application (2014-2019)
    11.2 NK Cell Therapy Market Forecast by Application (2019-2024)
    11.3 Cancer Revenue Growth (2014-2019)
    11.4 Gastrointestinal Diseases Revenue Growth (2014-2019)
    11.5 Others Revenue Growth (2014-2019)
12 Global NK Cell Therapy Market Size Forecast (2019-2024)
    12.1 Global NK Cell Therapy Market Size Forecast (2019-2024)
    12.2 Global NK Cell Therapy Market Forecast by Regions (2019-2024)
    12.3 North America NK Cell Therapy Revenue Market Forecast (2019-2024)
    12.4 Europe NK Cell Therapy Revenue Market Forecast (2019-2024)
    12.5 Asia-Pacific NK Cell Therapy Revenue Market Forecast (2019-2024)
    12.6 South America NK Cell Therapy Revenue Market Forecast (2019-2024)
    12.7 Middle East and Africa NK Cell Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Data Source
List of Tables and Figures

Figure NK Cell Therapy Picture
Table Product Specifications of NK Cell Therapy
Table Global NK Cell Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global NK Cell Therapy Revenue Market Share by Types in 2018
Figure NK Cell Therapies Picture
Figure NK Cell Directed Antibodies Picture
Table Global NK Cell Therapy Revenue (Million USD) by Application (2014-2024)
Figure NK Cell Therapy Revenue Market Share by Applications in 2018
Figure Cancer Picture
Figure Gastrointestinal Diseases Picture
Figure Others Picture
Table Global Market NK Cell Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America NK Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe NK Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific NK Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America NK Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa NK Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global NK Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table Nektar Therapeutics NK Cell Therapy Type and Applications
Table Nektar Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Kiadis Pharma Basic Information, Manufacturing Base and Competitors
Table Kiadis Pharma NK Cell Therapy Type and Applications
Table Kiadis Pharma NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Chipscreen Biosciences Basic Information, Manufacturing Base and Competitors
Table Chipscreen Biosciences NK Cell Therapy Type and Applications
Table Chipscreen Biosciences NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Innate Pharma SA Basic Information, Manufacturing Base and Competitors
Table Innate Pharma SA NK Cell Therapy Type and Applications
Table Innate Pharma SA NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Dragonfly Therapeutics Basic Information, Manufacturing Base and Competitors
Table Dragonfly Therapeutics NK Cell Therapy Type and Applications
Table Dragonfly Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Affimed Basic Information, Manufacturing Base and Competitors
Table Affimed NK Cell Therapy Type and Applications
Table Affimed NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Nkarta Therapeutics Basic Information, Manufacturing Base and Competitors
Table Nkarta Therapeutics NK Cell Therapy Type and Applications
Table Nkarta Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Glycostem Therapeutics Basic Information, Manufacturing Base and Competitors
Table Glycostem Therapeutics NK Cell Therapy Type and Applications
Table Glycostem Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Fate Therapeutics Basic Information, Manufacturing Base and Competitors
Table Fate Therapeutics NK Cell Therapy Type and Applications
Table Fate Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table NantWorks Basic Information, Manufacturing Base and Competitors
Table NantWorks NK Cell Therapy Type and Applications
Table NantWorks NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Fortress Biotech Basic Information, Manufacturing Base and Competitors
Table Fortress Biotech NK Cell Therapy Type and Applications
Table Fortress Biotech NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global NK Cell Therapy Revenue (Million USD) by Players (2014-2019)
Table Global NK Cell Therapy Revenue Share by Players (2014-2019)
Figure Global NK Cell Therapy Revenue Share by Players in 2017
Figure Global NK Cell Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players NK Cell Therapy Revenue Market Share in 2018
Figure Global Top 10 Players NK Cell Therapy Revenue Market Share in 2018
Figure Global NK Cell Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global NK Cell Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global NK Cell Therapy Revenue Market Share by Regions (2014-2019)
Figure Global NK Cell Therapy Revenue Market Share by Regions (2014-2019)
Figure Global NK Cell Therapy Revenue Market Share by Regions in 2018
Figure North America NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Europe NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure South America NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa NK Cell Therapy Revenue and Growth Rate (2014-2019)
Table North America NK Cell Therapy Revenue by Countries (2014-2019)
Table North America NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure North America NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure North America NK Cell Therapy Revenue Market Share by Countries in 2018
Figure USA NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Canada NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico NK Cell Therapy Revenue and Growth Rate (2014-2019)
Table Europe NK Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe NK Cell Therapy Revenue Market Share by Countries in 2018
Figure Germany NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure UK NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure France NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Russia NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Italy NK Cell Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific NK Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific NK Cell Therapy Revenue Market Share by Countries in 2018
Figure China NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Japan NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Korea NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure India NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia NK Cell Therapy Revenue and Growth Rate (2014-2019)
Table South America NK Cell Therapy Revenue by Countries (2014-2019)
Table South America NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure South America NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure South America NK Cell Therapy Revenue Market Share by Countries in 2018
Figure Brazil NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia NK Cell Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa NK Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa NK Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa NK Cell Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure UAE NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria NK Cell Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa NK Cell Therapy Revenue and Growth Rate (2014-2019)
Table Global NK Cell Therapy Revenue (Million USD) by Type (2014-2019)
Table Global NK Cell Therapy Revenue Share by Type (2014-2019)
Figure Global NK Cell Therapy Revenue Share by Type (2014-2019)
Figure Global NK Cell Therapy Revenue Share by Type in 2018
Table Global NK Cell Therapy Revenue Forecast by Type (2019-2024)
Figure Global NK Cell Therapy Market Share Forecast by Type (2019-2024)
Figure Global NK Cell Therapies Revenue Growth Rate (2014-2019)
Figure Global NK Cell Directed Antibodies Revenue Growth Rate (2014-2019)
Table Global NK Cell Therapy Revenue by Application (2014-2019)
Table Global NK Cell Therapy Revenue Share by Application (2014-2019)
Figure Global NK Cell Therapy Revenue Share by Application (2014-2019)
Figure Global NK Cell Therapy Revenue Share by Application in 2018
Table Global NK Cell Therapy Revenue Forecast by Application (2019-2024)
Figure Global NK Cell Therapy Market Share Forecast by Application (2019-2024)
Figure Global Cancer Revenue Growth Rate (2014-2019)
Figure Global Gastrointestinal Diseases Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global NK Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global NK Cell Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global NK Cell Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America NK Cell Therapy Revenue Market Forecast (2019-2024)
Figure Europe NK Cell Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific NK Cell Therapy Revenue Market Forecast (2019-2024)
Figure South America NK Cell Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa NK Cell Therapy Revenue Market Forecast (2019-2024)
Nektar Therapeutics
    Kiadis Pharma
    Chipscreen Biosciences
    Innate Pharma SA
    Dragonfly Therapeutics
    Affimed
    Nkarta Therapeutics
    Glycostem Therapeutics
    Fate Therapeutics
    NantWorks
    Fortress Biotech
Request sample
If you need any reports sample, just let us know
Request message: *
Your Name: *
Email Address: *
Country:
Phone Number:
Verification code: *
 
We aim to respond to all request on the same business day.

Purchase this Market Research Report

Single User License $3,480.00
Multi User License $5,220.00
Corporate Users License $6,960.00
Add to Cart Buy Now
goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico